{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:23:18Z","timestamp":1763036598447},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ypmed.2011.06.017","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T12:43:17Z","timestamp":1310215397000},"page":"127-130","source":"Crossref","is-referenced-by-count":12,"title":["Screening of women at high risk for breast cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Steven A.","family":"Narod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2011.06.017_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.354","article-title":"Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2","volume":"41","author":"Ahmed","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0010","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ng.669","article-title":"A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population","volume":"42","author":"Antoniou","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.2333031484","article-title":"Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer","volume":"233","author":"Berg","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0025","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/jnci\/94.20.1582","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO","volume":"94","author":"Bonadona","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer","volume":"356","author":"Boyd","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0035","article-title":"Is screening with magnetic resonance imaging in BRCA mutation carriers a safe and effective alternative to prophylactic mastectomy?","volume":"28","author":"Burness","year":"2011","journal-title":"J. Clin. Oncol. Mar."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0040","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/1055-9965.EPI-04-0394","article-title":"A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors","volume":"14","author":"Collett","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0045","unstructured":"Cybulski, C., Wokolorczyk, D., Jakubowska, A., et al. in press. The risk of breast cancer in women with a CHEK2 mutation, with and without a family history of breast cancer. J Clin Oncol."},{"issue":"3","key":"10.1016\/j.ypmed.2011.06.017_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2011.06.009","article-title":"Digital mammography screening: weighing reduced mortality against increased overdiagnosis","volume":"53","author":"de Gelder","year":"2011","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0050","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjc.6605877","article-title":"Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy","volume":"103","author":"Dores","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0055","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1470-2045(10)70263-1","article-title":"Mammographic surveillance in women younger than 50years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study","volume":"11","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrclinonc.2010.39","article-title":"Tumor size and survival in breast cancer\u2014a reappraisal","volume":"7","author":"Foulkes","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ypmed.2011.06.017_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.breast.2007.01.006","article-title":"Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series","volume":"16","author":"Hagen","year":"2007","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.ypmed.2011.06.017_bb0075","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/cncr.20221","article-title":"The development of interval breast malignancies in patients with BRCA mutations","volume":"100","author":"Komenaka","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0085","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","article-title":"Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer","volume":"23","author":"Kuhl","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/bcr10","article-title":"The pathology of familial breast cancer: morphological aspects","volume":"1","author":"Lakhani","year":"1999","journal-title":"Breast Cancer Res."},{"issue":"9473","key":"10.1016\/j.ypmed.2011.06.017_bb0100","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0105","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr2772","article-title":"A genome-wide association scan on estrogen receptor-negative breast cancer","volume":"12","author":"Li","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage","volume":"77","author":"Marcus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjc.6604830","article-title":"Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation","volume":"100","author":"Metcalfe","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0120","unstructured":"Metcalfe, K., et al., in press. Contralateral and ipsilateral mastectomy and survival after breast cancer in BRCA1 and BRCA2 mutation carriers."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0125","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/0008-5472.CAN-09-0851","article-title":"Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study","volume":"70","author":"Mouchawar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01402.x","article-title":"Testing for CHEK2 in the cancer genetics clinic: ready for prime time?","volume":"78","author":"Narod","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0135","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1118\/1.3512759","article-title":"Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast","volume":"37","author":"O'Connor","year":"2010","journal-title":"Med. Phys."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0140","unstructured":"Passaperuma, K., et al., in press. Long-term results of screening with magnetic resonance imaging in women with a BRCA1 or BRCA2 mutation."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0145","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa052911","article-title":"Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group","volume":"353","author":"Pisano","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0150","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","article-title":"Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging","volume":"295","author":"Plevritis","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa070608","article-title":"Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations","volume":"357","author":"Rennert","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.10100625","article-title":"Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts","volume":"258","author":"Rhodes","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0165","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0170","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr658","article-title":"A combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment","volume":"6","author":"Robson","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0180","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1158\/1078-0432.CCR-07-0689","article-title":"BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials","volume":"13","author":"Tilanus-Linthorst","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0185","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.ypmed.2011.06.017_bb0190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2011.06.017_bb0195","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2009.27.0835","article-title":"Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging","volume":"29","author":"Warner","year":"2011","journal-title":"J. Clin. Oncol."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351100243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174351100243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T10:51:02Z","timestamp":1543661462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174351100243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S009174351100243X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2011.06.017","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}